An observational study in Congenital Cataract, sponsored by yin ying zhao. Completed at 2 sites in China. Open to participants aged 10 Months to 72 Months. Per ClinicalTrials.gov, last updated 2019-10-09.
Sponsored by yin ying zhao · Observational
In this prospective study , a cohort of 58 eyes with congenital cataract from Wenzhou medical university was erolled.33 eyes with congenital cataract was after lensectomy and anterior vitrectomy as post-surger group, 26 eyes without cataract surgery as control group. The cytokines of MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15 was evaluated
Secondary IOL implantation in aphika children and lensectomy and anterior vitrectomy and primary IOL implantation in children with congenital cataract were both performed by the same surgeon(Z.Y.E) and videos were collected to review the capsular reconstruction condition and lens implantation position.
Aqueous humor (100-200 μl) was aspirated from each patient before the surgery. The research was to evaluate the relationship between the cytokine profile in aqueous humor and the state of capsule after Lensectomy and Anterior Vitrectomy.Aqueous humor was obtained , Human Magnetic Luminex Screening Assay was used to determine the aqueous humor levels of cytokines.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's enrollment of 59 is below the median of 81 across 484 observational studies indexed under Cataract.
Browse Cataract studies →yin ying zhao is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
congenital cataract age from 10 months to 72 months who underwent cataract surgery or aphakic children age from 15 months to 72 months who underwent secondary IOL implantation
Inclusion Criteria: aphakic children diagnosed with congenital cataract who underwent secondary IOL implantation and children with congenital cataract who underwent lensectomy and anterior vitrectomy and primary IOL implantation
Exclusion Criteria:patients with mild cataracts do not require surgery
-
aphakic children diagnosed with congenital cataract who underwent secondary IOL implantation
Procedure: secondary IOL implantation
children with congenital cataract who underwent lensectomy and anterior vitrectomy and primary IOL implantation
Procedure: primary IOL implantation
reopened the fibrotic, closed capsular bag and achieve IOL placement
lensectomy and anterior vitrectomy and primary IOL implantation
inflammatory cytokines
investigate inflammatory microenvironment changes in the aqueous of children after surgery.aqueous humor levels of cytokines, chemokines and growth factors including TGFβ2, TNF-α, IL-6, IP10, IL-10, MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15.
Time frame: before the surgery of secondary IOL implantation
This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
yin ying zhao